Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 4096 AL 4110

Molecular function of α7 nicotinic receptors as drug targets

Bouzat C, Lasala M, Nielsen BE, Corradi J, Esandi MDC.

J Physiol. 2018 May 15;596(10):1847-1861. doi: 10.1113/JP275101. Epub 2017 Nov 29.

Capgras Syndrome in Advanced Parkinson's Disease

Groth CL, Pusso A, Sperling SA, Huss DS, Elias WJ, Wooten GF, Barrett MJ.

J Neuropsychiatry Clin Neurosci. 2018 Spring;30(2):160-163. doi: 10.1176/appi.neuropsych.17030052. Epub 2017 Nov 14.

Considerations for general anaesthesia in Parkinson's disease

Roberts DP, Lewis SJG.

J Clin Neurosci. 2018 Feb;48:34-41. doi: 10.1016/j.jocn.2017.10.062. Epub 2017 Nov 10.

An introduction and overview of machine learning in neurosurgical care

Senders JT, Zaki MM, Karhade AV, Chang B, Gormley WB, Broekman ML, Smith TR, Arnaout O.

Acta Neurochir (Wien). 2018 Jan;160(1):29-38. doi: 10.1007/s00701-017-3385-8. Epub 2017 Nov 13.

Mechanistic contributions of FBXO7 to Parkinson disease

Joseph S, Schulz JB, Stegmüller J.

J Neurochem. 2018 Jan;144(2):118-127. doi: 10.1111/jnc.14253. Epub 2017 Dec 11.

MiRNAs participate in the diagnosis, pathogenesis and therapy of Parkinson's disease

Lu X, Cui Z, Liu S, Yin F.

Histol Histopathol. 2018 May;33(5):447-453. doi: 10.14670/HH-11-944. Epub 2017 Nov 14.

Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease

Lebois EP, Thorn C, Edgerton JR, Popiolek M, Xi S.

Neuropharmacology. 2018 Jul 1;136(Pt C):362-373. doi: 10.1016/j.neuropharm.2017.11.018. Epub 2017 Nov 11.

Neuromodulatory procedures for gait disorders in Parkinson's disease

Santens P.

Acta Neurol Belg. 2018 Mar;118(1):13-19. doi: 10.1007/s13760-017-0862-z. Epub 2017 Nov 14.

Repetitive Transcranial Magnetic Stimulation for Limb-Kinetic Apraxia in Parkinson's Disease

Park JE.

J Clin Neurol. 2018 Jan;14(1):110-111. doi: 10.3988/jcn.2018.14.1.110. Epub 2017 Oct 31.

Non-pharmacological interventions for Lewy body dementia: a systematic review

Connors MH, Quinto L, McKeith I, Brodaty H, Allan L, Bamford C, Thomas A, Taylor JP, O'Brien JT.

Psychol Med. 2018 Aug;48(11):1749-1758. doi: 10.1017/S0033291717003257. Epub 2017 Nov 16.

The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease

Piccinini G, Imbimbo I, Ricciardi D, Coraci D, Santilli C, Lo Monaco MR, Loreti C, Vulpiani MC, Silveri MC, Padua L.

Eur J Phys Rehabil Med. 2018 Aug;54(4):554-559. doi: 10.23736/S1973-9087.17.04837-7. Epub 2017 Nov 16.

Hypersexuality in Neurological Disorders: From Disinhibition to Impulsivity

Béreau M.

Front Neurol Neurosci. 2018;41:71-76. doi: 10.1159/000475693. Epub 2017 Nov 16.

REM Sleep Behavior Disorder

Bassetti CL, Bargiotas P.

Front Neurol Neurosci. 2018;41:104-116. doi: 10.1159/000478914. Epub 2017 Nov 16.

Diacylglycerols as biomarkers of sustained immune activation in Proteinopathies associated with dementia

Wood PL, Cebak JE, Woltjer RL.

Clin Chim Acta. 2018 Jan;476:107-110. doi: 10.1016/j.cca.2017.11.009. Epub 2017 Nov 13.

The effect of sensory-motor training on hand and upper extremity sensory and motor function in patients with idiopathic Parkinson disease

Taghizadeh G, Azad A, Kashefi S, Fallah S, Daneshjoo F.

J Hand Ther. 2018 Oct-Dec;31(4):486-493. doi: 10.1016/j.jht.2017.08.001. Epub 2017 Nov 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias